Z. Eshhar

发表

Conformational changes affect binding and catalysis by ester-hydrolysing antibodies.

Dan S. Tawfik, A. Lindner, Z. Eshhar, 1999, Journal of molecular biology.

Functional assembly of chimeric T-cell receptor chains.

Z. Eshhar, G. Gross, J. Lustgarten, 1992, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide.

Vyacheslav Kalchenko, Hadassa Degani, Niv Papo, 2006, Cancer research.

Production of Monoclonal Antibodies to Steroid Hormones

Z. Eshhar, H. R. Lindner, F. Kohen, 1982 .

Characterization of soman-binding antibodies raised against soman analogs.

R. Arad-Yellin, M. Glikson, Z. Eshhar, 1992, Molecular immunology.

Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells.

P. De Baetselier, S. Segal, Z. Eshhar, 1981, Journal of the National Cancer Institute.

Acknowledgement

D. Busch, H. Einsele, M. Dhodapkar, 1987, Hearing Research.

Use of monoclonal antibodies to pregnanediol-3α-glucuronide for the development of a solid phase chemiluminescence immunoassay

J. B. Kim, W. Collins, Z. Eshhar, 1981, Steroids.

Interspecies Comparison of Prostate Cancer Gene-expression Profiles Reveals Genes Associated with Aggressivetumors

E. Domany, I. Kela, Z. Eshhar, 2022 .

Monoclonal antibodies to the synthetic adjuvant muramyl dipeptide: characterization of the specificity.

F. Modabber, M. Sela, Z. Eshhar, 1983, Molecular immunology.

pH on-off switching of antibody-hapten binding by site-specific chemical modification of tyrosine.

Dan S. Tawfik, Z. Eshhar, B. Green, 1994, Protein engineering.

Adoptive Transfer of T-Bodies: Toward an Effective Cancer Immunotherapy

D. Friedmann-Morvinski, Z. Eshhar, 2009 .

The T-body approach: potential for cancer immunotherapy

Z. Eshhar, C. Fitzer-Attas, J. Lustgarten, 2004, Springer Seminars in Immunopathology.

Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes.

Z. Eshhar, A. Harmelin, H. Kanety, 2004, The Journal of clinical investigation.

CAR T cells: Building on the CD19 paradigm

M. Sadelain, Z. Eshhar, I. Rivière, 2021, European journal of immunology.

Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor.

Y. Yarden, I. Lax, J. Schlessinger, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Adoptive cancer immunotherapy using genetically engineered designer T-cells: First steps into the clinic.

Z. Eshhar, 2010, Current opinion in molecular therapeutics.

The T-body approach: redirecting T cells with antibody specificity.

Z. Eshhar, 2008, Handbook of experimental pharmacology.

Study on Adoptive Immunotherapy Using Gene-Modified TCells for Ovarian Cancer

S. Rosenberg, P. Hwu, S. Canevari, 2006 .

Transfer of chimeric receptor gene made of variable regions of tumor-specific antibody confers anticarbohydrate specificity on T cells.

S. Canevari, Z. Eshhar, A. Mazzoni, 1998, Cancer gene therapy.

Recognition of human colon cancer by T cells transduced with a chimeric receptor gene

P. Hwu, Z. Eshhar, Gang Wang, 2000, Cancer Gene Therapy.

Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.

M. Colombo, S. Canevari, Z. Eshhar, 1998, Cancer research.

Immune regulation of experimental myasthenia.

Z. Eshhar, D. Mochly‐Rosen, S. Fuchs, 1980, Journal of neurology, neurosurgery, and psychiatry.

Monoclonal antibodies associated with sodium channel block nerve impulse and stain nodes of Ranvier

V. Lev-Ram, J. Schlessinger, Z. Eshhar, 1984, Brain Research.

Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.

E. Elinav, Z. Eshhar, T. Waks, 2008, Gastroenterology.

Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor.

E. Elinav, Z. Eshhar, T. Waks, 2009, Gastroenterology.

Development of adoptive cell therapy for cancer: a clinical perspective.

T. Schumacher, N. Taylor, Z. Eshhar, 2010, Human gene therapy.

Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation.

D. Friedmann-Morvinski, Z. Eshhar, T. Waks, 2005, Blood.

CHANGES IN TUMOROGENIC AND METASTATIC PATTERN OF THYMOMA CELLS INDUCED BY THEIR HYBRIDIZATION TO NORMAL LYMPHOCYTES

R. Mandler, Z. Eshhar, 1982 .

New Strategy for the Redirection of Cytolytic T Lyphocytes to Breast Tumors

Z. Eshhar, 2001 .

A Human Monoclonal Antibody to Insulin

I. Cohen, Z. Eshhar, J. Sack, 1986, Diabetes.

WISH-PC 2 : A Unique Xenograft Model of Human Prostatic Small Cell Carcinoma 1

A. Belldegrun, Z. Eshhar, A. Harmelin, 2000 .

WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma.

A. Belldegrun, Z. Eshhar, A. Harmelin, 2000, Cancer research.

Human monoclonal antibody derived from an autoimmune thrombocytopenic purpura patient, recognizing an intermediate filament's determinant common to vimentin and desmin.

A. Berrebi, Z. Eshhar, D. Varón, 1990, Clinical immunology and immunopathology.

Use of monoclonal antibodies to a human cytotoxin for its isolation and for examining the self-induction of resistance to this protein.

Z. Eshhar, D. Wallach, D. Aderka, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Ferritin, a Hodgkin's disease associated antigen.

D. Katz, Z. Eshhar, S. Order, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Mixed alkanethiol monolayers on submicrometric gold patterns: a controlled platform for studying cell-ligand interactions.

U. Sivan, Z. Eshhar, Y. Reiter, 2012, Nano letters.

Engraftment and development of human T and B cells in mice after bone marrow transplantation.

Z. Eshhar, T. Lapidot, M. Levite, 1991, Science.

Chimeric T cell receptor which incorporates the anti-tumour specificity of a monoclonal antibody with the cytolytic activity of T cells: a model system for immunotherapeutical approach.

Z. Eshhar, G. Gross, 1990, The British journal of cancer. Supplement.

Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer

Z. Eshhar, A. Marcus, Zelig Eshhar, 2011, Oncotarget.

Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes

Z. Eshhar, J. Lustgarten, 1995, European journal of immunology.

Prolonged inhibition of IgE production in mice following treatment with an IgE-specific immunotoxin.

Z. Eshhar, J. Lustgarten, T. Waks, 1996, Molecular immunology.

Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE

Z. Eshhar, M. Baniyash, 1984, European journal of immunology.

Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilonRI-signaling gamma subunit.

Z. Eshhar, A. Annenkov, Y. Chernajovsky, 1998, Journal of immunology.

Quantitative detection of protein arrays.

A. Lindner, E. Moses, Z. Eshhar, 2003, Analytical chemistry.

Monoclonal antibodies specific to the alpha-subunit of the mast cell's Fc epsilon R block IgE binding and trigger histamine release.

Z. Eshhar, I. Alkalay, M. Baniyash, 1987, Journal of immunology.

Cell fractionation with affinity ligands conjugated to agarose-polyacrolein microsphere beads.

Z. Eshhar, S. Margel, M. Ofarim, 1983, Journal of cell science.

RAB-1: a new monoclonal antibody to leukemic hairy cells.

A. Berrebi, Z. Eshhar, S. Linder, 1986, Leukemia research.

Anti‐anti‐IgE idiotypic antibodies mimic IgE in their binding to the Fcϵ receptor

Z. Eshhar, M. Baniyash, Michal Baniyash, 1987, European journal of immunology.

ErbB2 is a tumor associated antigen and a suitable therapeutic target in Wilms tumor.

E. Fridman, G. Rechavi, Z. Eshhar, 2004, The Journal of urology.

Lymphoid Cell Surface Interaction Structures Detected Using Cytolysis‐Inhibiting Monoclonal Antibodies

Z. Eshhar, P. Golstein, C. Goridis, 1982, Immunological reviews.

T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor

D. Givol, Z. Eshhar, Y. Ben-Neriah, 1980, Nature.

Anti-IgE monoclonal antibodies directed at the Fcϵ receptor binding site

Z. Eshhar, M. Kehry, M. Baniyash, 1988 .

Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity.

Z. Eshhar, G. Gross, G. Gorochov, 1989, Transplantation proceedings.

Characterization and partial purification of antigenic components solubilized by a reversible chemical modification from rat-thymocyte membrane.

M. Sela, M. Bustin, Z. Eshhar, 1972, European journal of biochemistry.

Induction if immunological tolerance to the major antigenic determinant of penicillin: a therapeutic approach to penicillin allergy.

D. Katz, N. Chiorazzi, Z. Eshhar, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Mapping of the high affinity Fc epsilon receptor binding site to the third constant region domain of IgE.

Z. Eshhar, A. Nissim, M. Jouvin, 1991, The EMBO journal.

Somatic cell hybridization between bovine leukemia virus-infected lymphocytes and murine plasma cell tumors: cell fusion studies with bovine cells.

Z. Eshhar, S. Katzav, H. Ungar-Waron, 1982, Molecular immunology.

Induction of secretion of IgM from cells of the B cell line 38c-13 by somatic cell hybridization.

Y. Bergman, Z. Eshhar, C. Blatt, 1979, Journal of immunology.

LFA-1 but not Lyt-2 is associated with killing activity of cytotoxic T lymphocyte hybridomas

T. Springer, Z. Eshhar, P. Golstein, 1982, Nature.

Tumor-specific T-bodies: towards clinical application

Z. Eshhar, 1997, Cancer Immunology, Immunotherapy.

Fine specificity of the IgE interaction with the low and high affinity Fc receptor.

Z. Eshhar, A. Nissim, R. Siraganian, 1993, Journal of immunology.

Monoclonal antibodies against defined determinants of acetylcholine receptor

Z. Eshhar, S. Fuchs, D. Moshly-Rosen, 1979, FEBS letters.

Relationships between epitopes on IgE recognized by defined monoclonal antibodies and by the FC epsilon receptor on basophils.

Z. Eshhar, M. Baniyash, B. Rivnay, 1986, Journal of immunology.

Monoclonal antibodies for affinity purification of IL-6/IFN- beta 2 and for neutralization of HGF activity.

Z. Eshhar, D. Novick, Y. Mory, 1989, Hybridoma.

Affinity chromatography of human fibroblast interferon (IFN-beta 1) by monoclonal antibody columns.

Z. Eshhar, D. Novick, M. Rubinstein, 1983, The Journal of general virology.

Reorganization of arrays of prekeratin filaments during mitosis. Immunofluorescence microscopy with multiclonal and monoclonal prekeratin antibodies.

B. Geiger, Z. Eshhar, H. Kupfer, 1981, Experimental cell research.

Solubilization of lymphocyte and thymocyte antigens by a reversible chemical modification

M. Sela, D. Givol, Z. Eshhar, 1971, European journal of immunology.

CONTROL OF IMMUNOCOMPETENT CELL DIFFERENTIATION AND FUNCTION BY PRODUCTS OF THE MAJOR HISTOCOMPATIBILITY GENE COMPLEX

D. Katz, B. Benacerraf, M. Dorf, 1976 .

Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

Z. Eshhar, E. Zigmond, D. Blat, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.

Z. Eshhar, G. Gross, T. Waks, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.

Dan S. Tawfik, A. Lindner, Z. Eshhar, 1997, European journal of biochemistry.

1,8-Diazabicyclo[5.4.0]undecene Mediated Transesterification of p-Nitrophenyl Phosphonates: A Novel Route to Phosphono Esters

Dan S. Tawfik, Z. Eshhar, A. Bentolila, 1993 .

Mapping of distinct structural domains on microtubule-associated protein 2 by monoclonal antibodies.

B. Geiger, Z. Eshhar, T. Scherson, 1982, European journal of biochemistry.

Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGlu)-poly(DLAla)--poly(LLys). II. Evidence for a T-T-cell collaboration in delayed-type hypersensitivity responses and for a T- cell defect at the efferent phase in nonresponder H-2k mice

Z. Eshhar, G. Strassmann, E. Mozes, 1980, The Journal of experimental medicine.

Monoclonal Antibody Strategy and Techniques

Z. Eshhar, 1985 .

Serological characterisation of citrus tristeza virus isolates from Israel

Z. Eshhar, M. Bar-joseph, R. Gafny, 1994 .

Expression characteristics of two potential T cell mediator genes.

B. Kwon, Z. Eshhar, D. Kestler, 1989, Cellular immunology.

Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.

Z. Bentwich, Z. Eshhar, E. Hadas, 1986, Cancer research.

Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies.

Z. Eshhar, G. Vereb, H. Abken, 2020, Cancer letters.

Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors.

Y. Yarden, M. Sela, Z. Eshhar, 1993, Journal of immunology.

Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro.

Z. Eshhar, G. Berke, Y. Kaufmann, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Endowing T cells with antibody specificity using chimeric T cell receptors

Z. Eshhar, G. Gross, 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

Gang Wang, Steven A. Rosenberg, Zelig Eshhar, 2006, Clinical Cancer Research.

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity.

Z. Eshhar, G. Gross, T. Waks, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody–Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds

Z. Eshhar, Y. Reiter, H. Stauss, 2014, The Journal of Immunology.

Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity

Z. Eshhar, B. Tartakovsky, I. Avivi, 2020, Cancer Immunology Research.

Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell Therapy.

Z. Eshhar, G. Gross, 2016, Annual review of pharmacology and toxicology.

Monoclonal antibodies to human interferon‐gamma: production, affinity purification and radioimmunoassay.

Z. Eshhar, D. Novick, M. Rubinstein, 1983, The EMBO journal.

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

D. Friedmann-Morvinski, L. Álvarez-Vallina, Z. Eshhar, 2021, Nature communications.

Towards antibody-mediated metallo-porphyrin chemistry

E. Keinan, Z. Eshhar, S. Sinha, 1990 .

Variability and repertoire size of T-cell receptor Vα gene segments

Mark M. Davis, K. Arai, Y. Chien, 1985, Nature.

Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer.

Steffen Jung, Z. Eshhar, E. Yeini, 2018, Nanomedicine : nanotechnology, biology, and medicine.

Mapping of murine IgE epitopes involved in IgE‐Fcε receptor interactions

Y. Bergman, Z. Eshhar, I. Alkalay, 1989 .

Photodynamic therapy with Pd‐bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenografts

Avigdor Scherz, Yoram Salomon, Zelig Eshhar, 2003, International journal of cancer.

Adoptive immunotherapy of cancer using effector lymphocytes redirected with antibody specificity

D. Friedmann-Morvinski, Z. Eshhar, 2006 .

Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes.

Z. Eshhar, A. Harmelin, H. Kanety, 2003, Cancer research.

In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.

S. Rosenberg, P. Hwu, Z. Eshhar, 1995, Cancer research.

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain

S. Rosenberg, P. Hwu, Z. Eshhar, 1993, The Journal of experimental medicine.

Anti-Collagen Antibody and Fc Receptor Containing Single-Chain Fv of an Chimeric Cell Hybridomas Transduced with a Loss of Original Antigenic Specificity in T

Z. Eshhar, A. Annenkov, Y. Chernajovsky, 2017 .

Loss of Original Antigenic Specificity in T Cell Hybridomas Transduced with a Chimeric Receptor Containing Single-Chain Fv of an Anti-Collagen Antibody and FcεRI-Signaling γ Subunit

Z. Eshhar, A. Annenkov, Y. Chernajovsky, 1998, The Journal of Immunology.

Protective monoclonal antibody against Schistosoma mansoni: antigen isolation, characterization, and suitability for active immunization.

Z. Eshhar, F. Levi-Schaffer, R. Arnon, 1985, Journal of immunology.

The human mast cell receptor binding site maps to the third constant domain of immunoglobulin E.

Z. Eshhar, A. Nissim, 1992, Molecular immunology.

Localization of the FcεRI binding site to the third constant domain of IgE

Z. Eshhar, A. Nissim, 1991 .

Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity.

Z. Eshhar, T. Waks, M. Ofarim, 1980, Journal of immunology.

Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft.

W. Sellers, Z. Eshhar, A. Orr-Urtreger, 2002, Cancer research.

T-bodies as antiviral agents.

P. Debré, Z. Eshhar, G. Gorochov, 2001, Current topics in microbiology and immunology.

Gene therapy approaches to HIV-infection: immunological strategies: use of T bodies and universal receptors to redirect cytolytic T-cells.

P. Debré, Z. Eshhar, G. Gorochov, 1999, Frontiers in bioscience : a journal and virtual library.

Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice.

P. Altevogt, Z. Eshhar, H. Abken, 2012, Gastroenterology.

Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts

Z. Eshhar, A. Harmelin, L. Agemy, 2008, The Prostate.

Transport of 3-o-Methylglucose Into and Out of Storage Cells of Daucus carota.

Z. Eshhar, L. Reinhold, 1968, Plant physiology.

Measurement of plasma estradiol-17 beta by solid-phase chemiluminescence immunoassay.

J. B. Kim, W. Collins, Z. Eshhar, 1982, Clinical chemistry.

Novel assay procedure for assessing ovarian function in women.

J. B. Kim, W. Collins, Z. Eshhar, 1981, Journal of steroid biochemistry.

T cell derived IgE binding factors inhibit IgE-specific rosettes on basophilic leukaemic cells and lymphocytes.

Z. Eshhar, M. Firer, 1986, Immunology letters.

Anti‐schistosome monoclonal antibodies of different isotypes–correlation with cytotoxicity.

Z. Eshhar, R. Arnon, S. Horowitz, 1983, The EMBO journal.

Monoclonal immunoglobulin G augments hydrolysis of an ester of the homologous hapten

Z. Eshhar, H. R. Lindner, F. Kohen, 1980, FEBS letters.

Fine specificity and idiotypic expression of monoclonal antibodies directed against poly(Tyr,Glu)-poly(DLAla)--poly(Lys) and its ordered analogue (Tyr-Tyr-Glu-Glu)-poly(DLAla)--poly(Lys).

Z. Eshhar, E. Mozes, B. Parhami-Seren, 1983, Immunology.

Characteristics of a poly(LTyr,LGlu)‐poly(DLAla)–poly(LLys)‐specific helper factor derived from a T cell hybridoma

Z. Eshhar, H. Zinger, E. Mozes, 1981, European journal of immunology.

CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor‐antigen complex

Z. Eshhar, J. Lustgarten, T. Waks, 1991, European journal of immunology.

Activation of T and B lymphocytes in vitro. V. Cellular locus, metabolism and genetics of induction, and production of the allogeneic effect factor.

D. Katz, Z. Eshhar, T. Waks, 1977, Journal of immunology.

In vitro and in vivo induction of effector T cells mediating DTH responses to a protein and a synthetic polypeptide antigen.

Z. Eshhar, G. Strassmann, E. Mozes, 1979, Cellular immunology.

Harnessing Syk family tyrosine kinases as signaling domains for chimeric single chain of the variable domain receptors: optimal design for T cell activation.

Z. Eshhar, C. Fitzer-Attas, T. Waks, 1998, Journal of immunology.

Direct T Cell Activation by Chimeric Single Chain Fv-Syk Promotes Syk-Cbl Association and Cbl Phosphorylation*

Z. Eshhar, C. Fitzer-Attas, T. Waks, 1997, The Journal of Biological Chemistry.

Detection of a cytokeratin determinant common to diverse epithelial cells by a broadly cross‐reacting monoclonal antibody.

B. Geiger, R. Moll, Z. Eshhar, 1982, The EMBO journal.

HISTOCOMPATIBILITY GENE PRODUCTS AS MEDIATORS OF LYMPHOCYTE INTERACTIONS

D. Katz, Z. Eshhar, D. Armerding, 1976 .

T-Bodies: Antibody-Based Engineered T-Cell Receptors

Z. Eshhar, H. Abken, D. Gilham, 2014 .

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR

J W Gratama, Z. Eshhar, J. Gratama, 2000, Gene Therapy.

Epigen, the Last Ligand of ErbB Receptors, Reveals Intricate Relationships between Affinity and Mitogenicity*

A. Citri, V. Chalifa-Caspi, Y. Yarden, 2005, Journal of Biological Chemistry.

A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling Domains Leads to Enhanced Survival of Transduced T Lymphocytes and Antitumor Activity1

S. Rosenberg, M. Sadelain, R. Morgan, 2009, The Journal of Immunology.

Lymphocytes and Antitumor Activity Leads to Enhanced Survival of Transduced T Receptor with Modified Signaling Domains A Herceptin-Based Chimeric Antigen

S. Rosenberg, Z. Eshhar, Yangbing Zhao, 2009 .

Monoclonal Antibodies for Purification and RIA of Natural and Recombinant Human Interferon-α, -β And-γ

Z. Eshhar, Y. Chernajovsky, D. Novick, 1985 .

Monoclonal antibodies to human alpha-interferon and their use for affinity chromatography.

Z. Eshhar, D. Novick, M. Rubinstein, 1982, Journal of immunology.

Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells.

Z. Eshhar, T. Waks, A. Globerson-levin, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

From the mouse cage to human therapy: a personal perspective of the emergence of T-bodies/chimeric antigen receptor T cells.

Z. Eshhar, 2014, Human gene therapy.

The emergence of T-bodies/CAR T cells.

Z. Eshhar, G. Gross, T. Waks, 2014, Cancer journal.

Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer

Z. Eshhar, A. Marcus, 2014, Expert opinion on biological therapy.

Functional relationships of lymphocyte membrane structures probed with cytolysis and/or proliferation-inhibiting H35-27.9 and H35-89.9 monoclonal antibodies.

Z. Eshhar, P. Golstein, M. Luciani, 1982, Advances in experimental medicine and biology.

Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach

Z. Eshhar, T. Waks, V. Vainstein, 2020, Cancer Immunology, Immunotherapy.

Adoptive Cell Therapy of Systemic Metastases Using erbB-2-Specific T Cells Redirected with a Chimeric Antibody-Based Receptor

D. Friedmann-Morvinski, Z. Eshhar, T. Waks, 2014 .

X-Ray structures of two families of hydrolytic antibodies

B. Golinelli‐Pimpaneau, Z. Eshhar, J. Charbonnier, 1998 .

Expression and characterization of recombinant single-chain Fv and Fv fragments derived from a set of catalytic antibodies.

Dan S. Tawfik, S. Kim, A. Lindner, 1997, Molecular immunology.

X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release.

Z. Eshhar, J. Charbonnier, Marcel Knossow, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Structural Convergence in the Active Sites of a Family of Catalytic Antibodies

Dan S. Tawfik, S. Kim, B. Golinelli‐Pimpaneau, 1997, Science.

Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity.

Dan S. Tawfik, Z. Eshhar, D. Schindler, 1994, Molecular immunology.

Cytotoxic T cell hybridomas: generation and characterization.

Z. Eshhar, T. Waks, G. Berke, 1982, Current topics in microbiology and immunology.

Chimaeric T-cell receptors specific to a B-lymphoma idiotype: a model for tumour immunotherapy.

S. Levy, Z. Eshhar, G. Gross, 1995, Biochemical Society transactions.

Tumor-specific allogeneic cells for cancer therapy

Z. Eshhar, A. Marcus, 2011, Expert opinion on biological therapy.

Redirected tumor-specific allogeneic T cells for universal treatment of cancer.

Z. Eshhar, T. Waks, A. Marcus, 2011, Blood.

Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?

Dan S. Tawfik, M. Sela, Z. Eshhar, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Monoclonal anti‐VH antibodies recognize a common VH determinant expressed on immunoglobulin heavy chains from various species

D. Givol, Z. Eshhar, Y. Ben-Neriah, 1983, European journal of immunology.

Growth inhibition of prostate cancer xenografts by halofuginone * †

A. Nagler, M. Pines, Z. Eshhar, 2002, The Prostate.

Crystal structure of a catalytic antibody Fab with esterase-like activity.

Dan S. Tawfik, J. Navaza, B. Golinelli‐Pimpaneau, 1994, Structure.

Catalytic antibodies: A critical assessment

Dan S. Tawfik, Z. Eshhar, D S Tawfik, 1994, Molecular biotechnology.

Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.

Dan S. Tawfik, R. Arad-Yellin, Z. Eshhar, 1990, Biochemistry.

Monoclonal Antibodies to Human Leukocyte and Fibroblast Interferon

Z. Eshhar, M. Rubinstein, M. Revel, 1983 .

Catalytic Antibodies as Mechanistic and Structural Models of Hydrolytic Enzymes

Dan S. Tawfik, A. Lindner, Z. Eshhar, 2008 .

Esterolytic antibodies as mechanistic and structural models of hydrolases-a quantitative analysis.

Dan S. Tawfik, A. Lindner, Z. Eshhar, 2002, Journal of molecular biology.

Mechanism of inactivation of a catalytic antibody by p-nitrophenyl esters.

B. Golinelli‐Pimpaneau, Z. Eshhar, J. Charbonnier, 1997, European journal of biochemistry.

Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.

B. Golinelli‐Pimpaneau, Z. Eshhar, J. Charbonnier, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Detection of catalytic monoclonal antibodies.

Dan S. Tawfik, Z. Eshhar, B. Green, 1992, Analytical biochemistry.

Functional expression of chimeric receptor genes in human T cells.

Z. Eshhar, T. Waks, D. Schindler, 2001, Journal of immunological methods.

T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields

Z. Ram, Z. Eshhar, R. Grossman, 2021, The Journal of Immunology.

Preparation of monoclonal antibodies able to discriminate between testosterone and 5α-dihydrotestosterone

Z. Eshhar, H. R. Lindner, F. Kohen, 1982, Steroids.

Specificity of heterologous antisera to components solubilized from rat thymocyte membranes

Z. Eshhar, 1973, European journal of immunology.

Isolation of thymocytes by affinity chromatography.

M. Bustin, Z. Eshhar, T. Waks, 1974, Methods in Enzymology.

Monoclonal Antibodies to the Human Interferon-γ Receptor: Blocking of the Biological Activities of Interferon-γ and Purification of the Receptor

Z. Eshhar, D. Novick, M. Rubinstein, 1989 .

Anti-IgE monoclonal antibodies directed at the Fc epsilon receptor binding site.

Z. Eshhar, M. Kehry, M. Baniyash, 1988, Molecular immunology.

catELISA: a facile general route to catalytic antibodies.

Dan S. Tawfik, M. Sela, Z. Eshhar, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Induction of tolerance to nucleic acid determinants by administration of a complex of nucleoside D-glutamic acid and D-lysine (D-GL).

D. Katz, B. Benacerraf, Z. Eshhar, 1975, Journal of immunology.

Suppression of Human Prostate Tumor Growth in Mice by a Cytolytic d-, l-Amino Acid Peptide

Y. Shai, N. Papo, Z. Eshhar, 2004, Cancer Research.

Gene Expression Profiles Predict Sensitivity of Prostate Cancer to Radiotherapy

E. Domany, I. Kela, Z. Eshhar, 2013 .

Unusual Alternative Splicing within the Human Kallikrein Genes KLK2 and KLK3 Gives Rise to Novel Prostate-specific Proteins*

L. Mintz, Sharon Engel, A. Toporik, 2002, The Journal of Biological Chemistry.

Activation of T and B lymphocytes in vitro. VI. Biochemical and physicochemical characterization of the allogeneic effect factor.

D. Katz, Z. Eshhar, D. Armerding, 1977, Journal of immunology.

Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker.

Michal Neeman, Avigdor Scherz, Yoram Salomon, 2004, Neoplasia.

Opinion paper on the current status of the regulation of gene therapy in Europe.

R. Vile, G. Gahrton, C. Melani, 2002, Human Gene Therapy.

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the y or C subunits of the immunoglobulin and T-cell receptors ( single-chain Fv domain / chimeric receptors / Immunotargeting / T cell )

Z. Eshhar, T. Waks, D. Schindler, 2004 .

T cell hybridomas producing antigen-specific factors express heavy-chain variable-region determinants.

Z. Eshhar, H. Zinger, E. Mozes, 1982, Current topics in microbiology and immunology.

Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGu)-poly(DLAla)--poly(LLys). I. Expression of the genetic defect at two phases of the immune process

Z. Eshhar, G. Strassmann, E. Mozes, 1980, The Journal of experimental medicine.

Functional expression in mast cells of chimeric receptors with antibody specificity

Z. Eshhar, T. Waks, D. Schindler, 2007, Cell Biophysics.

Electrically controlled molecular recognition harnessed to activate a cellular response.

U. Sivan, Z. Eshhar, Y. Reiter, 2011, Nano letters.

Like Lytic Peptide − Systemic Inoculation of a Host Defense Metastases in Human Prostate and Breast Xenografts by Inhibition of Tumor Growth and Elimination of Multiple

H. Degani, Y. Shai, N. Papo, 2006 .

Differences Amoung Individual CEA Preparations and Carcinomas of Different Origin as Detected by Monoclonal Anti-CEA Antibodies

N. Ariel, Z. Eshhar, R. Arnon, 1984 .

Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.

Z. Eshhar, E. Zigmond, D. Blat, 2014, Molecular Therapy.

Interspecies comparison of prostate cancer gene‐expression profiles reveals genes associated with aggressive tumors

E. Domany, I. Kela, Z. Eshhar, 2009, The Prostate.

Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor.

E. Elinav, Z. Eshhar, T. Waks, 2009, Gastroenterology.

Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.

Z. Eshhar, J. Charbonnier, Marcel Knossow, 1998, Journal of molecular biology.

STRUCTURES OF ESTERASE-LIKE CATALYTIC ANTIBODIES

Z. Eshhar, J. Charbonnier, Marcel Knossow, 1999 .

CAR's made it to the pancreas

Z. Eshhar, H. Abken, M. Chmielewski, 2012, Oncoimmunology.

Anti-leucocyte function-associated antigen-1 antibodies inhibit T-cell activation following low-avidity and adhesion-independent interactions.

Z. Eshhar, G. Gross, G. Gorochov, 1993, Immunology.

Calpain (Ca(2+)-dependent thiol protease) in erythrocytes of young and old individuals.

Z. Eshhar, S. Barnoy, N. Kosower, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Identification of a surface antigen, common to murine lung and lewis lung carcinoma, by monoclonal antibody

Z. Eshhar, E. Hadas, E. Hurwitz, 1984, International journal of cancer.